Evidence map›Paper›PMID 40216893›Full record

ArticleScientific reports2025

Predicting metabolic dysfunction associated steatotic liver disease using explainable machine learning methods.

Yihao Yu, Yuqi Yang, Qian Li, Jing Yuan, Yan Zha

Abstract read
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Review
  8. Review
  9. Article
  10. Review
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Yihao Yu *Master of Finance, Australian National University, Canberra, Australia.
Yuqi Yang *Department of Nephrology, Guizhou Provincial People's Hospital, Guiyang, 550002, China.
Qian LiDepartment of Nephrology, Guizhou Provincial People's Hospital, Guiyang, 550002, China.
Jing YuanDepartment of Nephrology, Guizhou Provincial People's Hospital, Guiyang, 550002, China.
Yan ZhaDepartment of Nephrology, Guizhou Provincial People's Hospital, Guiyang, 550002, China. zhayan72@126.com.

Funding

Guizhou Provincial Science and Technology Department QKH-ZK[2023]-219Guizhou Science & Technology Department QKHCG2023-ZD010National Natural Science Foundation of China 82160144
6 · The paper itself

Abstract

Early and accurate identification of patients at high risk of metabolic dysfunction-associated steatotic liver disease (MASLD) is critical to prevent and improve prognosis potentially. We aimed to develop and validate an explainable prediction model based on machine learning (ML) approaches for MASLD among the adult population. The national cross-sectional study collected data from the National Health and Nutrition Examination Survey from 2017 to 2020, consisting of 13,436 participants, who were randomly split into 70% training, 20% internal validation, and 10% external validation cohorts. MASLD was defined based on transient elastography and cardiometabolic risk factors. With 50 medical characteristics easily obtained, six ML algorithms were used to develop prediction models. Several evaluation parameters were used to compare the predictive performance, including the area under the receiver-operating-characteristic curve (AUC) and precision-recall (P-R) curve. The recursive feature elimination method was applied to select the optimal feature subset. The Shapley Additive exPlanations method offered global and local explanations for the model. The random forest (RF) model performed best in discriminative ability among 6 ML models, and the optimal 10-feature RF model was finally chosen. The final model could accurately predict MASLD in internal and external validation cohorts (AUC: 0.928, 0.918; area under P-R curve: 0.876, 0.863, respectively). The final model performed better than each of the traditional risk indicators for MASLD. An explainable 10-feature prediction model with excellent discrimination and calibration performance was successfully developed and validated for MASLD based on clinical data easily extracted using an RF algorithm.

Indexed as

Fatty LiverMachine LearningAdultAgedAlgorithmsArea Under CurveCross-Sectional StudiesElasticity Imaging TechniquesFemaleHumansMaleMiddle AgedNutrition SurveysRisk FactorsROC CurveMachine learningMetabolic dysfunction-associated steatotic liver diseasePrediction modelSHAP

Identifiers

PMID40216893
PMCPMC11992218

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.